After doing your 24th neurological exam on your off-service neurology rotation, and realizing that you’re almost too good at them now and not even using a list anymore to make sure you don’t forget the finger to nose, heel to shin, and rapid alternating movements test, you are given a patient to follow that reminds you of being back in the Emergency Department. You go crazy thanking the neurologists and buy them all donuts and coffee for reminding you of life downstairs.
A 23-year-old male with an unknown psychiatric history is brought in by EMS for altered mental status. On exam, he is febrile to 104 F, diaphoretic, pale, bradyreflexic, and he has severe, “lead-pipe” rigidity.
What is the differential diagnosis? Serotonin syndrome, CNS infections, sepsis, drug-induced hyperthermic syndromes, anticholinergic poisoning, sympathomimetic toxicity, malignant hyperthermia, neuroleptic malignant syndrome
What is neuroleptic malignant syndrome (NMS)?
True or False? The antipsychotic serum concentration is usually outside the therapeutic range in setting of NMS? False. It is usually within the therapeutic range
What is the incidence of NMS? 1 to 2 cases per 10,000 patients who are treated with antipsychotics
What are the clinical manifestations of NMS? The presentation involves a tetrad of fever, muscular rigidity (“lead-pipe” and “cogwheel rigidity”), autonomic dysfunction, and altered mental status (including lethargy, agitation, mutism, or coma) that develop over a period of 1 to 3 days
What are common laboratory abnormalities associated with NMS? Elevated CK, leukocytosis, transaminitis, hypernatremia or hyponatremia, metabolic acidosis, myoglobinuria, elevated BUN and Cr, and low iron level
Don’t be fooled!
How do you treat NMS?
What are the potential complications of NMS? Rhabdomyolysis, renal failure, respiratory failure, DIC, cardiovascular collapse, and death
Sources:
Dosi R, et al. “Serotonin syndrome versus neuroleptic malignant syndrome: a challenging clinical quandary.” BMJ Case Rep. 2014 Jun 23;2014.
Kateon, H. “Differentiating serotonin syndrome and neuroleptic malignant syndrome.” Mental Health Clinician: September 2013, Vol. 3, No. 3, pp. 129-133.
Tintinalli, J, et al. Tintinalli’s Emergency Medicine: A Comprehensive Study Guide. 8th Edition. 2016.
https://lifeinthefastlane.com/ccc/neuroleptic-malignant-syndrome/
https://lifeinthefastlane.com/ccc/hyperthermia-associated-toxidromes/
Surriya
Latest posts by Surriya (see all)
- October Food & Journal Club – Geriatric Edition - November 18, 2019
- Neuroleptic Malignant Syndrome – The Fundamentals - December 12, 2017
- Just another Alcoholic? Approach to Alcohol Related Conditions in the ED - October 24, 2017
0 Comments